Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
SIB Swiss Institute of Bioinformatics | RCV001007566 | SCV001426220 | uncertain significance | Beck-Fahrner syndrome | 2020-07-22 | criteria provided, single submitter | curation | This variant is interpreted as a variant of uncertain significance for Beck-Fahrner syndrome, autosomal recessive. The following ACMG Tag(s) were applied: Absent from controls (or at extremely low frequency if recessive) in Exome Sequencing Project, 1000 Genomes Project, or Exome Aggregation Consortium (PM2); For recessive disorders, detected in trans with a (likely)pathogenic variant (PM3). |
Ambry Genetics | RCV004030286 | SCV004964555 | uncertain significance | Inborn genetic diseases | 2021-12-16 | criteria provided, single submitter | clinical testing | The c.1849C>T (p.R617C) alteration is located in exon 1 (coding exon 1) of the TET3 gene. This alteration results from a C to T substitution at nucleotide position 1849, causing the arginine (R) at amino acid position 617 to be replaced by a cysteine (C). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |
Clinical Genomics Laboratory, |
RCV001007566 | SCV005045077 | uncertain significance | Beck-Fahrner syndrome | 2024-02-20 | criteria provided, single submitter | clinical testing | The TET3 c.2254C>T (p.Arg752Cys) variant has been reported in one individual affected with Beck-Fahrner syndrome who harbored this variant and an additional variant of uncertain significance, confirmed in trans, in a compound heterozygous state (Beck DB et al., PMID: 31928709). The highest population minor allele frequency in the population database genome aggregation database (v.2.1.1) is 0.033% in the South Asian population. Computational predictors suggest that the variant does not impact TET3 function. This variant has been reported in the ClinVar database as a germline likely pathogenic variant and variant of uncertain significance by two submitters. Due to limited information, and based on ACMG/AMP guidelines for variant interpretation (Richards S et al., PMID: 25741868), the clinical significance of this variant is uncertain at this time. |
Clinical Genetics Laboratory, |
RCV004697023 | SCV005198772 | uncertain significance | not provided | 2022-11-14 | criteria provided, single submitter | clinical testing | |
OMIM | RCV001007566 | SCV001167187 | pathogenic | Beck-Fahrner syndrome | 2020-06-16 | no assertion criteria provided | literature only | |
University of Washington Center for Mendelian Genomics, |
RCV001257922 | SCV001434731 | likely pathogenic | TET3 deficiency | no assertion criteria provided | research |